Johannes Laengle, MD, PhD
3 clinical trials · Sponsor
◉ Watch Johannes Laengle, MD, PhD
| Record | Firm | Date |
|---|---|---|
| Immunoscore As Decision Guidance for Adjuvant Chemotherapy in Colon Cancer (NCT04488159) | Johannes Laengle, MD, PhD | 2024-12-01 |
| PD-L1 PET Imaging During Neoadjuvant (Chemo)Radiotherapy in Esophageal and Rectal Cancer (NCT04564482) | Johannes Laengle, MD, PhD | 2022-11-01 |
| Neoadjuvant Chemoradiotherapy With Sequential Ipilimumab and Nivolumab in Rectal Cancer (NCT04124601) | Johannes Laengle, MD, PhD | 2020-06-01 |
Track Johannes Laengle, MD, PhD automatically
Every clearance here is in the API, with alerts when new ones post.